Financial Daily from THE HINDU group of publications
Thursday, Dec 01, 2005
Financial Daily from THE HINDU group of publications Thursday, Dec 01, 2005 |
|
|
|
|
|
|
|
Corporate
-
Alliances & Joint Ventures IRL-Synexus tie up for patient recruitment sites Our Bureau
(From right) Mr S.R. Dugal, Chairman, IRL, with Dr Ian Geoffrey Smith, MD, Synexus Clinical Research Plc, and Mr Vijay Moza, Vice-Chairman & CEO, IRL, at a press conference in Mumbai on Wednesday. - Paul Noronha
Mumbai , Nov. 30 ICRI Research (P) Ltd (IRL), an associate of ICRI, the world's largest clinical research institute, has entered into a strategic alliance with the UK-based Synexus Clinical Research Plc to establish India's first-ever patient-recruitment site management organisation with dedicated investigator sites, to undertake Phase II-Phase IV global clinical trials. Synexus is the largest patient recruitment organisation in Europe, undertaking clinical trials for pharmaceutical companies and contract research organisations. IRL-Synexus will offer a chain of exclusive, fully-owned GCP-compliant investigator sites across India, for fast and effective patient recruitment and deliver reliable, high-quality data on schedule. Each IRL-Synexus clinical research centre will have GCP trained research staff — qualified doctors, nurses, data coordinators and administrators. Mr Shivraman Dugal, Chairman, IRL, and Dr Ian Smith, Managing Director, Synexus Clinical Research Plc, made this joint announcement here on Wednesday. "India possesses tremendous potential to become a preferred location for research and development for the global biotechnology and pharmaceutical sector. According to a McKinsey report, the global clinical trial outsourcing opportunity in India in the pharmaceutical industry is estimated to be around Rs 5,000 crore by the year 2010, and there will be requirement of approximately 50,000 clinical research professionals. Our association with Synexus will certainly help us tap the ever-growing global market," said Mr Dugal. IRL-Synexus will work in all therapeutic areas where OPD-based studies can be undertaken. It will ensure active patient participation for each clinical study and source patients through internationally accepted recruitment methods. Mr Vijay Moza, Vice-Chairman and CEO, IRL, said, "Synexus resembles our philosophy, ethics and business values. We are extremely happy to have UK's largest patient recruitment organisation, Synexus as our partner in India. IRL will leverage Synexus's experience, network, and innovative and ethically approved patient recruitment methods."
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page More Stories on : Alliances & Joint Ventures
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|